Potential role of cholinesterases to predict short-term outcome after hepatic resection for hepatocellular carcinoma

Updates in Surgery

Volumn 65, Issue 1, 2013, Pages 11-18

  Donadon, Matteo ^a   Cimino, Matteo ^a   Procopio, Fabio ^a   Morenghi, Emanuela ^b   Montorsi, Marco ^a   Torzilli, Guido ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Cholinesterases; Cirrhosis; Functional liver reserve; Hepatocellular carcinoma; Liver resection; MELD score

Indexed keywords

CHOLINESTERASE;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PROGNOSIS; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHOLINESTERASES; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84874606054     PISSN: 2038131X     EISSN: 20383312     Source Type: Journal    
DOI: 10.1007/s13304-012-0174-z     Document Type: Article

References (36)

1. Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236:397-407
2. Imamura H, Seyama Y, Kokudo N et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198-1206
3. Makuuchi M, Donadon M, Torzilli G (2008) Hepatic resection for hepatocellular carcinoma in cirrhosis. Ann Ital Chir 79:111-115
4. Mullen JT, Ribero D, Reddy SK et al (2007) Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204:854-862
5. McQueen MJ (1995) Clinical and analytical considerations in the utilization of cholinesterase measurements. Clin Chim Acta 237:91-105
6. Chiarla C, Giovannini I, Giuliante F et al (2001) Plasma cholinesterase correlations in acute surgical and critical illness. Minerva Chir 66:323-327
7. Torzilli G, Donadon M, Marconi M et al (2008) Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona clinic liver cancer classification: results of a prospective analysis. Arch Surg 143:1082-1090
8. Terminology Committee of the IHPBA (2000) Terminology of liver anatomy and resections. HPB Surg 2:333-339
9. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6,336 patients and results of a survey. Ann Surg 240:205-213
10. Torzilli G, Montorsi M, Del Fabbro D et al (2006) Ultrasonographically guided surgical approach to liver tumours involving the hepatic veins close to the caval confluence. Br J Surg 93:1238-1246
11. Torzilli G, Montorsi M, Donadon M et al (2005) "Radical but conservative" is the main goal for ultrasonography-guided liver resection: prospective validation of this approach. J Am Coll Surg 201:517-528
12. Japanese Research Society for Portal Hypertension (1980) The general rules for recording endoscopic findings on esophageal varices. Jpn J Surg 19:84-87
13. Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-699
14. Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-649
15. Malinchoc M, Kamath PS, Gordon FD et al (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864-871
16. Torzilli G, Gambetti A, Del Fabbro D et al (2004) Techniques for hepatectomies without blood transfusion, focusing on interpretation of postoperative anemia. Arch Surg 139:1061-1065
17. Torzilli G, Olivari N, Del Fabbro D et al (2005) Bilirubin level fluctuation in drain discharge after hepatectomies justifies long-term drain maintenance. Hepatogastroenterology 52:1206-1210
18. Bektas M, Idilman R, Soykan I et al (2008) Adjuvant therapeutic plasma exchange in liver failure: assessments of clinical and laboratory parameters. J Clin Gastroenterol 42:517-521
19. Livraghi T, Meloni F, Di Stasi M et al (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47:82-89
20. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36
21. Teh SH, Christein J, Donohue J et al (2005) Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model of end-stage liver disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 9:1207-1215
22. Schroeder RA, Marroquin CE, Phillips Bute B et al (2006) Predictive indices of morbidity and mortality after liver resection. Ann Surg 243:373-379
23. Llovet JM, Brú C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329-338
24. Lau WY, Lai EC (2008) Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 7:237-257
25. Mullin EJ, Metcalfe MS, Maddern GJ (2005) How much liver resection is too much? Am J Surg 190:87-97
26. Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298-304
27. Kamath PS, Wiesner RH, Malinchoc M et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464-470
28. Cucchetti A, Ercolani G, Vivarelli M et al (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12:966-971
29. Torzilli G, Donadon M, Marconi M et al (2008) Systematic extended right posterior sectionectomy: a safe and effective alternative to right hepatectomy. Ann Surg 247:603-611
30. Cucchetti A, Ercolani G, Cescon M et al (2006) Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J Am Coll Surg 203:670-676
31. Balzan S, Belghiti J, Farges O et al (2005) The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824-828
32. Kutty KM (1980) Review: biological function of cholinesterase. Clin Biochem 13:239-243
33. Schmidt E, Schmidt FW, Lautz U et al (1989) Biochemical aspects of transplantation. In: Den Boer MC, van der Heiden C, Leijuse B, Souverijn JHM (eds) Clinical chemistry. An overview. Plenum Press, New York-London, pp 345-353
34. Schmidt E (1978) Strategy and evaluation of enzyme determinations in serum in diseases of the liver and the biliary system. In: Demers LM, Shaw LM (eds) Evaluation of Liver Function. Urban and Schwarzenberg, Baltimore Munich, pp 79-101
35. Schmidt E, Schmidt FW (1993) Enzyme diagnosis of liver diseases. Clin Biochem 26:241-251
36. Ishizawa T, Hasegawa K, Kokudo N et al (2009) Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg 144:46-51